Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Gains from Sales and Divestitures (2020 - 2026)

Exponent (EXPO) has disclosed Gains from Sales and Divestitures for 6 consecutive years, with $223386.0 as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Gains from Sales and Divestitures fell 16.29% year-over-year to $223386.0, compared with a TTM value of $223386.0 through Jan 2026, down 16.29%, and an annual FY2026 reading of $223386.0, down 16.29% over the prior year.
  • Gains from Sales and Divestitures was $223386.0 for Q1 2026 at Exponent, down from $266859.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $313072.0 in Q4 2022 and bottomed at $223386.0 in Q1 2026.
  • Average Gains from Sales and Divestitures over 4 years is $262957.5, with a median of $257686.0 recorded in 2023.
  • The sharpest move saw Gains from Sales and Divestitures fell 20.62% in 2023, then increased 7.38% in 2025.
  • Year by year, Gains from Sales and Divestitures stood at $313072.0 in 2022, then dropped by 20.62% to $248513.0 in 2023, then rose by 7.38% to $266859.0 in 2025, then decreased by 16.29% to $223386.0 in 2026.
  • Business Quant data shows Gains from Sales and Divestitures for EXPO at $223386.0 in Q1 2026, $266859.0 in Q1 2025, and $248513.0 in Q4 2023.